Fresenius Medical Care AG (XTER:FME) EBIT: €1,851 Mil (TTM As of Mar. 2026)


XTER:FME Fresenius Medical Care AG XTER:FME
70 GF Score
Price €41.55
GF Value €41.29
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Fresenius Medical Care AG EBIT?

Fresenius Medical Care AG XTER:FME +0.73% 70 EBIT is €1,851 Mil as of Mar. 2026. GuruFocus rates XTER:FME with a GF Score™ of 70/100 and a GF Value™ of €41.29 (Fairly Valued). The stock has 4 warning signs investors should review.

Fresenius Medical Care AG's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was €301 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was €1,851 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Fresenius Medical Care AG's annualized ROC % for the quarter that ended in Mar. 2026 was 4.18%. Fresenius Medical Care AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 14.60%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Fresenius Medical Care AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 8.60%.


Fresenius Medical Care AG  (XTER:FME) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Fresenius Medical Care AG's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=1502.22 * ( 1 - 20.6% )/( (27971.083 + 29046.942)/ 2 )
=1192.76268/28509.0125
=4.18 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=31002.333 - 1377.953 - ( 1821.289 - max(0, 6245.103 - 7898.4+1821.289))
=27971.083

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=31467.593 - 1042.218 - ( 1623.341 - max(0, 6729.52 - 8107.953+1623.341))
=29046.942

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Fresenius Medical Care AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=1203.264/( ( (6499.795 + max(1533.304, 0)) + (6443.302 + max(2010.509, 0)) )/ 2 )
=1203.264/( ( 8033.099 + 8453.811 )/ 2 )
=1203.264/8243.455
=14.60 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3161.303 + 2140.771 + 279.001) - (1377.953 + 114.365 + 2555.453)
=1533.304

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3582.043 + 2303.007 + 466.173) - (1042.218 + 0 + 3298.496)
=2010.509

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Fresenius Medical Care AG's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=1851.095/21527.811
=8.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fresenius Medical Care AG EBIT Related Terms


Fresenius Medical Care AG EBIT Historical Data

* Premium members only.

The historical data trend for Fresenius Medical Care AG's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius Medical Care AG EBIT Chart

Fresenius Medical Care AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,925.46 1,579.42 1,457.66 1,463.97 1,896.65

Fresenius Medical Care AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 346.37 447.14 495.66 607.48 300.82

XTER:FME vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, Fresenius Medical Care AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius Medical Care AG EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Fresenius Medical Care AG's EV-to-EBIT falls into.


XTER:FME
70GF Score
Fresenius Medical Care AG XTER:FME
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fresenius Medical Care AG EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €1,851 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €1,851 Mil mean?
Fresenius Medical Care AG (XTER:FME) has a EBIT of €1,851 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Fresenius Medical Care AG.
Is Fresenius Medical Care AG's EBIT too high?
Fresenius Medical Care AG's current EBIT is €1,851 Mil. Overall, Fresenius Medical Care AG has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's EBIT compare to HCA and THC?
Fresenius Medical Care AG's EBIT of €1,851 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Fresenius Medical Care AG. Fresenius Medical Care AG's current EBIT is €1,851 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Based on GuruFocus' analysis, Fresenius Medical Care AG (XTER:FME) is currently considered Fairly Valued. The stock's GF Value™ is €41.29, compared to a current price of €41.55 — trading 0.6% above its estimated fair value. The current EBIT is €1,851 Mil. Fresenius Medical Care AG's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Fresenius Medical Care AG (XTER:FME), the current EBIT is €1,851 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius Medical Care AG (XTER:FME) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be overvalued. The current stock price of €41.55 is trading 0.6% above its estimated GF Value™ of €41.29. GuruFocus considers Fresenius Medical Care AG to be Fairly Valued.

Key valuation signals for XTER:FME:

  • EBIT: €1,851 Mil
  • GF Value™: €41.29 vs. price of €41.55 (0.6% above fair value)
  • GF Score™: 70/100 with 4 warning signs

No single metric tells the full story. See the XTER:FME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fresenius Medical Care AG Business Description

Address Else-Kroner-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
70GF Score

Get the complete analysis for XTER:FME

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€41.55
Price
€41.29
GF Value